Heterogeneous nuclear ribonucleoprotein A2/B1 (
hnRNP A2/B1) plays an important role in influence of pre-
messenger RNA (
pre-mRNA) processing and
mRNA metabolism and transportation in cells. Increasing evidence indicates that
hnRNP A2/B1 played an important role in development and progression of various human
cancers. Forty cases of normal and human
glioma tissue samples were analyzed using immunohistochemistry to reveal the expression of
hnRNP A2/B1
protein in the samples. Then, knockdown of
hnRNP A2/B1 expression induced by RNA interference (RNAi) method was used to analyze the role of
hnRNP A2/B1 in
glioblastoma cell viability, adhesion, migration, invasion, and chemoresistance for
temozolomide (TMZ). The data showed that
hnRNP A2/B1
protein was overexpressed in
glioma tissue specimens and associated with advanced
glioma grades. Knockdown of
hnRNP A2/B1 could reduce
glioblastoma cell viability, adhesion, migration, invasion, and chemoresistance for TMZ capacity, but induced
tumor cells to apoptosis and
reactive oxygen species (ROS) generation in
glioma U251 and SHG44 cells. Molecularly,
hnRNP A2/B1 knockdown reduced expression of phospho-STAT3 and MMP-2. Detection of
hnRNP A2/B1 expression may be useful as a
biomarker for prediction of
glioma progression and knockdown of
hnRNP A2/B1 expression as a novel strategy in future control of
glioblastoma in clinic.